Hannah S. White

Person

Chapel Hill, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Morphic forms of trilaciclib and methods of manufacture thereof
- Patent number 12,168,666
- Issue date Dec 17, 2024
- G1 Therapeutics, Inc.
- Stephen Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Morphic forms of G1T38 and methods of manufacture thereof
- Patent number 12,139,494
- Issue date Nov 12, 2024
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
- Patent number 11,708,337
- Issue date Jul 25, 2023
- G1 Therapeutics, Inc.
- Stephen E. Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
- Patent number 11,629,150
- Issue date Apr 18, 2023
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 11,446,295
- Issue date Sep 20, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Morphic forms of G1T38 and methods of manufacture thereof
- Patent number 11,261,193
- Issue date Mar 1, 2022
- GI Therapeutics, Inc.
- Alexander Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Morphic forms of trilaciclib and methods of manufacture thereof
- Patent number 10,988,479
- Issue date Apr 27, 2021
- G1 Therapeutics, Inc.
- Stephen Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines
- Patent number 10,865,210
- Issue date Dec 15, 2020
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 10,231,969
- Issue date Mar 19, 2019
- GI Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One
- Publication number 20240199556
- Publication date Jun 20, 2024
- G1 Therapeutics, Inc.
- Stephen E. Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...
- Publication number 20230241059
- Publication date Aug 3, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF
- Publication number 20230043305
- Publication date Feb 9, 2023
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF
- Publication number 20210387993
- Publication date Dec 16, 2021
- G1 Therapeutics, Inc.
- Stephen Schneider
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE
- Publication number 20210179567
- Publication date Jun 17, 2021
- G1 Therapeutics, Inc.
- Stephen E. Schneider
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES
- Publication number 20210122755
- Publication date Apr 29, 2021
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF
- Publication number 20200123168
- Publication date Apr 23, 2020
- G1 Therapeutics, Inc.
- Alexander Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...
- Publication number 20190151311
- Publication date May 23, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES
- Publication number 20190135820
- Publication date May 9, 2019
- G1 Therapeutics, Inc.
- Alexander Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20190030034
- Publication date Jan 31, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-Neoplastic Combinations and Dosing Regimens using CDK4/6 Inhib...
- Publication number 20170182043
- Publication date Jun 29, 2017
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Hannah S. White

Person

Patents Grantslast 30 patents

Morphic forms of trilaciclib and methods of manufacture thereof

Morphic forms of G1T38 and methods of manufacture thereof

Synthesis of 1,4-diazaspiro[5.5]undecan-3-one

Synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Morphic forms of G1T38 and methods of manufacture thereof

Morphic forms of trilaciclib and methods of manufacture thereof

Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Patents Applicationslast 30 patents

Synthesis of 1,4-Diazaspiro[5.5]Undecan-3-One

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...

MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

SYNTHESIS OF 1,4-DIAZASPIRO[5.5]UNDECAN-3-ONE

SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES

MORPHIC FORMS OF G1T38 AND METHODS OF MANUFACTURE THEREOF

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...

SYNTHESIS OF N-(HETEROARYL)-PYRROLO[3,2-D]PYRIMIDIN-2-AMINES

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...

Anti-Neoplastic Combinations and Dosing Regimens using CDK4/6 Inhib...